According to GlobalData, the decision of the US regulator is likely to hurt Medtronic's sales, which currently occupies ...

The seriousness of this latest recall can be expected to have a noticeable effect on Medtronic’s laryngoscope sales.

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.

During the quarter, broad U.S. equity markets rose amid moderating inflation, strong corporate earnings growth and weakening ...

Zacks Investment Research does not engage in investment banking, market making or asset management activities of any ...

Cential Robotics today announced it appointed Lisa Jacobs and Matthiew Ville to its leadership team to accelerate growth in ...

Merit predicts the portfolio, which includes devices used in procedures to remove or replace heart rhythm device leads, will add $40 million a year to its sales.

Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for ...

BlueWind Medical, a pioneer in implantable Tibial NeuroModulation (iTNM) and the developer of Revi®, a patient-centric ...

We recently compiled a list of Morgan Stanley’s Best Stock Picks: 15 Stocks To Own For 2025. In this article, we are going to ...